While a concerted effort to boost research on women's health over the last two decades has lessened the burden cardiovascular disease, breast cancer and cervical cancer, the effort has yielded less progress on other fronts. NBC's Robert Bazell reports.
(Washington, DC) — The National Coalition for Osteoporosis and Related Bone Diseases applauds Rep. Berkley (D-NV), Rep. Burgess (R-TX) and the more than 60 Members of Congress who have joined together to introduce the Bone Health Promotion and Research Act of 2009. "We are pleased to have bipartisan support for this timely legislation which will educate Americans about achieving better bone health as well as help people who suffer from debilitating bone diseases, fulfilling the call to action from the Surgeon General's 2004 Report on, Bone Health and Osteoporosis," stated Ethel S.
Researchers have been looking into a possible link between the use of bisphosphonate medicines, such as alendronate (Fosamax®), ibandronate (Boniva®), risedronate (Actonel®) and zoledronic acid (Reclast®) and an unusual type of broken bone in the femur (thigh bone). Bisphosphonate medicines are prescribed to reduce the risk of fractures (broken bones) in people with osteoporosis.
Researchers have been looking into a possible link between the use of oral bisphosphonate medications, such as alendronate (Fosamax®), ibandronate (Boniva®) and risedronate (Actonel®) and an increased risk of esophageal cancer. Bisphosphonate medications are prescribed to reduce the risk of fractures (broken bones).
WASHINGTON, DC (August 26, 2010) - The National Osteoporosis Foundation (NOF) mourns the passing of Lawrence G. Raisz, MD, long time member of the NOF Board of Trustees, who served as the NOF Vice President until the time of his death. Dr. Raisz's service to NOF was extensive. He played a critical role in the organization from its inception; first as Chair of the Scientific Advisory Board and subsequently as a member of the Board of Trustees. While serving as Vice President, Dr.
The National Osteoporosis Foundation (NOF) named four new members to its Board of Trustees last month during its annual meeting. NOF welcomes Susan Greenspan, M.D., L. Scott Scharer, Peter F. Schwartz and Heidi Skolnik as new members.
Osteoporosis is a silent disease until it is complicated by fractures—fractures that can occur following minimal trauma. These fractures are common and place an enormous medical and personal burden on aging individuals and a major economic toll on the nation. Osteoporosis can be prevented and can be diagnosed and treated before any fracture occurs. Importantly, even after the first fracture has occurred, there are effective treatments to decrease the risk of further fractures. Prevention, detection and treatment of osteoporosis should be a mandate of primary care providers.
National Geographic travel writer Marybeth Bond and her daughter, JC, bicycled from San Francisco to New York City this June and July, to raise awareness of osteoporosis and to raise funds for the National Osteoporosis Foundation (NOF). Their 3,000 mile ride, through five National Parks and seven cities, raised more than $27,500. Their efforts were supported by Total® cereal, who matched 100 percent of their fundraising efforts up to $25,000.
FOR IMMEDIATE RELEASE
Contact: Lisa Wolfington
lisaw@nof.org
(202) 772-1126
The National Osteoporosis Foundation and U.S. Department of Health and Human Services Launch Unique Campaign for Girls Called “Best Bones Forever!”
(Washington, DC) — The National Coalition for Osteoporosis and Related Bone Diseases applauds Rep. Berkley (D-NV), Rep. Burgess (R-TX) and the more than 60 Members of Congress who have joined together to introduce the Bone Health Promotion and Research Act of 2009. "We are pleased to have bipartisan support for this timely legislation which will educate Americans about achieving better bone health as well as help people who suffer from debilitating bone diseases, fulfilling the call to action from the Surgeon General's 2004 Report on, Bone Health and Osteoporosis," stated Ethel S.